Loading
Latest filing published 05 Mar 2013 for BIOMIMETIC THERAPEUTICS, INC..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
James G. Murphy has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Immunicon Corp and Biomimetic Therapeutics, Inc. The record holds 20 filings, for trades running from 17 November 2006 to 1 March 2013.
The open-market record is one-sided, with 12 purchases worth €54k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 3 option exercises.
A typical purchase (the median) is worth €2,446.
On 5 March 2013 came the latest disclosure, an option exercise for €83k in Biomimetic Therapeutics, Inc. The last insider purchase was made public on 29 June 2009, 6,325 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations